Experimental systems to study the origin of the myofibroblast in peritoneal fibrosis = Experimental systems to study the origin of the myofibroblast in peritoneal fibrosis

다국어 초록 (Multilingual Abstract)

Peritoneal fibrosis is one of the major complications occurring in long-term peritoneal dialysis patients as a result of injury. Peritoneal fibrosis is characterized by submesothelial thickening and fibrosis which is associated with a decline in peritoneal membrane function. The myofibroblast has been identified as the key player involved in the development and progression of peritoneal fibrosis. Activation of the myofibroblast is correlated with expansion of the extracellular matrix and changes in peritoneal membrane integrity. Over the years, epithelial to mesenchymal transition (EMT) has been accepted as the predominant source of the myofibroblast. Peritoneal mesothelial cells have been described to undergo EMT in response to injury. Several animal and in vitro studies support the role of EMT in peritoneal fibrosis; however, emerging evidence from genetic fate-mapping studies has demonstrated that myofibroblasts may be arising from resident fibroblasts and pericytes/perivascular fibroblasts. In this review, we will discuss hypotheses currently surrounding the origin of the myofibroblast and highlight the experimental systems predominantly being used to investigate this.

참고문헌 (Reference)

1 Iwaisako K, "What's new in liver fibrosis? The origin of myofibroblasts in liver fibrosis" 2 : 65-68, 2012

2 Zhang J, "Vascular endothelial growth factor expression in peritoneal mesothelial cells undergoing transdifferentiation" 28 : 497-504, 2008

3 Kim YL, "Update on mechanisms of ultrafiltration failure" 2 : s123-127, 2009

4 Zuk A, "Type I collagen gel induces Madin-Darby canine kidney cells to become fusiform in shape and lose apicalbasal polarity" 108 : 903-919, 1989

5 Margetts PJ, "Transient overexpression of TGF-{beta}1 induces epithelial mesenchymal transition in the rodent peritoneum" 16 : 425-436, 2004

6 Fan JM, "Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro" 56 : 1455-1467, 1999

7 Margetts PJ, "Transforming growth factor beta-induced peritoneal fibrosis is mouse strain dependent" 28 : 2015-2027, 2013

8 Desmoulie re A, "Tissue repair, contraction, and the myofibroblast" 13 : 7-12, 2005

9 Zweers MM, "The standard peritoneal permeability analysis in the rabbit : a longitudinal model for peritoneal dialysis" 19 : 56-64, 1999

10 Grgic I, "The origin of interstitial myofibroblasts in chronic kidney disease" 27 : 183-193, 2012

11 Hinz B, "The myofibroblast : one function, multiple origins" 170 : 1807-1816, 2007

12 Kalluri R, "The basics of epithelial-mesenchymal transition" 119 : 1420-1428, 2009

13 McLoughlin RM, "Switching on EMT in the peritoneal membrane : considering the evidence" 26 : 12-15, 2011

14 Patel P, "Smad3-dependent and-independent pathways are involved in peritoneal membrane injury" 77 : 319-328, 2010

15 Joseph MJ, "Slug is a downstream mediator of transforming growth factor-beta1-induced matrix metalloproteinase-9 expression and invasion of oral cancer cells" 108 : 726-736, 2009

16 Rajkumar VS, "Shared expression of phenotypic markers in systemic sclerosis indicates a convergence of pericytes and fibroblasts to a myofibroblast lineage in fibrosis" 7 : r1113-1123, 2005

17 Sabeh F, "Secreted versus membrane-anchored collagenases : relative roles in fibroblastdependent collagenolysis and invasion" 284 : 23001-23011, 2009

18 Quaggin SE, "Scar wars : mapping the fate of epithelialmesenchymal-myofibroblast transition" 80 : 41-50, 2011

19 Piera-Velazquez S, "Role of endothelial-mesenchymal transition(EndoMT)in the pathogenesis of fibrotic disorders" 179 : 1074-1080, 2011

20 Zeisberg M, "Resolved. EMT produces fibroblasts in the kidney" 21 : 1247-1253, 2010

21 Strutz F, "Renal fibroblasts and myofibroblasts in chronic kidney disease" 17 : 2992-2998, 2006

22 Liu L, "Prolonged peritoneal gene expression using a helper-dependent adenovirus" 29 : 508-516, 2009

23 Ask K, "Progressive pulmonary fibrosis is mediated by TGF-beta isoform 1 but not TGF-beta3" 40 : 484-495, 2008

24 Patel P, "Platelet derived growth factor B and epithelial mesenchymal transition of peritoneal mesothelial cells" 29 : 97-106, 2010

25 Flessner MF, "Peritoneal inflammation after twenty-week exposure to dialysis solution : effect of solution versus catheter-foreign body reaction" 30 : 284-293, 2010

26 Ya~nez-Mo M, "Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells" 348 : 403-413, 2003

27 LeBleu VS, "Origin and function of myofibroblasts in kidney fibrosis" 19 : 1047-1053, 2013

28 Desmoulie re A, "Normal and pathologic soft tissue remodeling : role of the myofibroblast, with special emphasis on liver and kidney fibrosis" 83 : 1689-1707, 2003

29 Tomasek JJ, "Myofibroblasts and mechano-regulation of connective tissue remodelling" 3 : 349-363, 2002

30 Williams JD, "Morphologic changes in the peritoneal membrane of patients with renal disease" 13 : 470-479, 2002

31 Aroeira LS, "Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis : role of vascular endothelial growth factor" 46 : 938-948, 2005

32 Mutsaers SE, "Mechanisms of tissue repair : from wound healing to fibrosis" 29 : 5-17, 1997

33 Chen YT, "Lineage tracing reveals distinctive fates for mesothelial cells and sub-mesothelial fibroblasts during peritoneal injury" 25 : 2847-2858, 2014

34 Yanagita M, "Inhibitors/antagonists of TGF-b system in kidney fibrosis" 27 : 3686-3691, 2012

35 Seok J, "Inflammation and Host Response to Injury, Large Scale Collaborative Research Program: Genomic responses in mouse models poorly mimic human inflammatory diseases" 110 : 3507-3512, 2013

36 Honda K, "Impact of uremia, diabetes, and peritoneal dialysis itself on the pathogenesis of peritoneal scle-rosis : a quantitative study of peritoneal membrane morphology" 3 : 720-728, 2008

37 Krediet RT, "Impact of surface area and permeability on solute clearances" 3 : s70-77, 1994

38 Duffield JS, "Host responses in tissue repair and fibrosis" 8 : 241-276, 2013

39 Braun N, "Histological criteria for encapsulating peritoneal sclerosis e a standardized approach" e48647-, 2012

40 Siddique I, "Gremlin promotes peritoneal membrane injury in an experimental mouse model and is associated with increased solute transport in peritoneal dialysis patients" 184 : 2976-2984, 2014

41 Margetts PJ, "Gene transfer of transforming growth factor-beta1to the rat peritoneum : effects on membrane function" 12 : 2029-2039, 2001

42 Hinz B, "Formation and function of the myofibroblast during tissue repair" 127 : 526-537, 2007

43 Baum J, "Fibroblasts and myofibroblasts: what are we talking about?" 57 : 376-379, 2011

44 Humphreys BD, "Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis" 176 : 85-97, 2010

45 Lameire N, "Experimental models in peritoneal dialysis : a European experience" 54 : 2194-2206, 1998

46 Hoff CM, "Experimental animal models of encapsulating peritoneal sclerosis" 4 : s57-66, 2005

47 Iwano M, "Evi-dence that fibroblasts derive from epithelium during tissue fibrosis" 110 : 341-350, 2002

48 Park MS, "Evaluation of an experimental rat model for perito-neal dialysis : fluid and solute transport characteristics" 9 : 404-412, 1994

49 Lovisa S, "Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis" 21 : 998-1009, 2015

50 Kalluri R, "Epithelial-mesenchymal transition and its implications for fibrosis" 112 : 1776-1784, 2003

51 Aroeira LS, "Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients : pathologic significance and potential therapeutic interventions" 18 : 2004-2013, 2007

52 Greenburg G, "Epithelia suspended in collagen gels can lose polarity and express characteristics of migrating mesenchymal cells" 95 : 333-339, 1982

53 Mactier RA, "Contribution of lymphatic absorption to loss of ultrafiltration and solute clearances in continuous ambulatory peritoneal dialysis" 80 : 1311-1316, 1987

54 Aroeira LS, "Characterization of epithelial-tomesenchymal transition of mesothelial cells in a mouse model of chronic peritoneal exposure to high glucose dialysate" 5 : s29-33, 2008

55 Hinz B, "Cell-matrix and cell-cell contacts of myofi-broblasts : role in connective tissue remodeling" 90 : 993-1002, 2003

56 Loureiro J, "Blocking TGF-b 1 protects the peritoneal membrane from dialysate-induced damage" 22 : 1682-1695, 2011

57 Cho JH, "Are ex vivo mesothelial cells representative of the in vivo transition from epithelial-tomesenchymal cells in peritoneal membrane?" 27 : 1768-1779, 2012

58 Ishii Y, "An experimental sclerosing encapsulating peritonitis model in mice" 16 : 1262-1266, 2001

59 Mactier RA, "Absorption of fluid and solutes from the peritoneal cavity. Theoretic and therapeutic implications and applications" 35 : 122-131, 1989

60 Margetts PJ, "A chronic inflam-matory infusion model of peritoneal dialysis in rats" 3 : s368-372, 2001